Palmatier, Katelyn2012-09-122012-09-122012-04-18https://hdl.handle.net/11299/133312Faculty Advisor: Dr. Carston R. WagnerTo maximize the effectiveness and minimize the adverse effects of chemotherapeutic agents, it is strategic to create drugs that specifically target cancer cells via ligand-receptor interactions. Several variations of a drug containing a ligand that binds to Death Receptor 5 were created and in vitro properties were characterized.en-USCollege of PharmacyDepartment of Medicinal ChemistryWagner GroupPresentation